These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7167609)

  • 1. Use and misuse of the MMPI in multiple sclerosis.
    Marsh GG; Hirsch SH; Leung G
    Psychol Rep; 1982 Dec; 51(3 Pt 2):1127-34. PubMed ID: 7167609
    [No Abstract]   [Full Text] [Related]  

  • 2. Use and misuse of the MMPI, a reconsideration.
    Mueller SR; Girace M
    Psychol Rep; 1988 Oct; 63(2):483-91. PubMed ID: 3222415
    [No Abstract]   [Full Text] [Related]  

  • 3. The validity of the MMPI with multiple sclerosis patients.
    Meyerink LH; Reitan RM; Selz M
    J Clin Psychol; 1988 Sep; 44(5):764-9. PubMed ID: 3192715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMPI correlates with disability in multiple sclerosis.
    Davis LJ; Osborne D; Siemens PJ; Brown JR
    Psychol Rep; 1971 Jun; 28(3):700-2. PubMed ID: 4397470
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29).
    Smedal T; Johansen HH; Myhr KM; Strand LI
    Acta Neurol Scand; 2010 Oct; 122(4):244-51. PubMed ID: 19951267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personality characteristics and multiple sclerosis.
    Wilson H; Olson WH; Gascon GG; Brumback RA
    Psychol Rep; 1982 Dec; 51(3 Pt 1):791-806. PubMed ID: 7163438
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring personality and emotional functioning in multiple sclerosis: a cautionary note.
    Nelson LD; Elder JT; Tehrani P; Groot J
    Arch Clin Neuropsychol; 2003 May; 18(4):419-29. PubMed ID: 14591455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis.
    Cano SJ; Barrett LE; Zajicek JP; Hobart JC
    Mult Scler; 2011 Feb; 17(2):214-22. PubMed ID: 20947530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: a comparison with ulcerative colitis.
    Bol Y; Duits AA; Vertommen-Mertens CE; Hupperts RM; Romberg-Camps MJ; Verhey FR; Vlaeyen JW
    J Psychosom Res; 2010 Jul; 69(1):43-9. PubMed ID: 20630262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
    Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMPI profiles in exacerbation and remission of multiple sclerosis.
    Cleeland CS; Matthews CG; Hopper CL
    Psychol Rep; 1970 Oct; 27(2):373-4. PubMed ID: 4394977
    [No Abstract]   [Full Text] [Related]  

  • 12. MMPI responses of patients with multiple sclerosis.
    SHONTZ FC
    J Consult Psychol; 1955 Feb; 19(1):74. PubMed ID: 14354097
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MMPI in differentiating early multiple sclerosis and conversion hysteria.
    Dodge GR; Kolstoe RH
    Psychol Rep; 1971 Aug; 29(1):155-9. PubMed ID: 4398406
    [No Abstract]   [Full Text] [Related]  

  • 15. Another look at MMPI profile types in multiple sclerosis.
    GILBERSTADT H; FARKAS E
    J Consult Psychol; 1961 Oct; 25():440-4. PubMed ID: 13898531
    [No Abstract]   [Full Text] [Related]  

  • 16. Memory impairment in multiple sclerosis.
    Minden SL; Moes EJ; Orav J; Kaplan E; Reich P
    J Clin Exp Neuropsychol; 1990 Aug; 12(4):566-86. PubMed ID: 2211978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMPI testing for multiple sclerosis.
    Hovey HB
    Psychol Rep; 1967 Oct; 21(2):599-600. PubMed ID: 4383938
    [No Abstract]   [Full Text] [Related]  

  • 18. The development and validation of the impact of multiple sclerosis scale and the symptoms of multiple sclerosis scale.
    McMillan L; Moore KA
    Arch Phys Med Rehabil; 2006 Jun; 87(6):832-41. PubMed ID: 16731220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coping with multiple sclerosis: a 5-year follow-up study.
    Lode K; Bru E; Klevan G; Myhr KM; Nyland H; Larsen JP
    Acta Neurol Scand; 2010 Nov; 122(5):336-42. PubMed ID: 20047563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
    Bagnato F; Salman Z; Kane R; Auh S; Cantor FK; Ehrmantraut M; Gallo A; Ikonomidou VN; Ohayon J; Pellicano C; Stern SK; McFarland HF
    Mult Scler; 2010 Oct; 16(10):1203-12. PubMed ID: 20699284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.